FIELD: medicine, cardiology. SUBSTANCE: method involves determination of blood sphingomyelin content in patient on the 2-d day of disease. Myocardium infarction is diagnosed at the level of sphingomyelin above 1900 mcmole phosphorus/1 l blood. Infarction myocardium size is determined by the formula: M = 0.054 x C - 99.1 where M - necrosis size expressed as percent of aortic ventricle of heart mass; C - content of blood sphingomyelins (as mcmoles/1 l blood). EFFECT: high precision of assay in one's lifetime. 4 ex, 1 tbl
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD FOR PREDICTING A LATENTLY PROGRESSING ISCHEMIC CARDIAC DISEASE IN PATIENTS WITH ARTERIAL HYPERTENSION | 2001 |
|
RU2197180C1 |
| METHOD OF DETERMINING VENOUS STASIS ON SYSTEMIC CIRCULATION IN PATIENTS WITH CHRONIC HEART FAILURE | 2010 |
|
RU2449289C2 |
| METHOD FOR SETTING DIFFERENTIAL DIAGNOSIS OF ISCHEMIC AND HEMORRHAGIC INSULT IN THE UTMOST ACUTE PERIOD | 2000 |
|
RU2175446C1 |
| METHOD OF MYOCARDIAL INFARCTION DIAGNOSIS | 0 |
|
SU1802341A1 |
| DIFFERENTIAL DIAGNOSIS METHOD FOR DETECTING THE CASES OF DILATED CARDIOMYOPATHY AND CARDIAC ISCHEMIA DISEASE ACCORDING TO ECHOCARDIOGRAPHIC EXAMINATION DATA | 2006 |
|
RU2299684C1 |
| METHOD OF PREDICTING EFFICIENCY OF INTERCOSTAL IMPLANTATION IN MAXILLOFACIAL PATIENTS | 1997 |
|
RU2127885C1 |
| METHOD OF DISEASE OUTCOME PREDICTION IN ELDERLY AND OLD PATIENTS SUFFERING FROM CARDIAC INSUFFICIENCY | 2007 |
|
RU2353933C1 |
| METHOD FOR CORRECTING BONE TISSUE STATUS AND PREVENTING FRACTURES IN CARDIOVASCULAR PATIENTS | 2013 |
|
RU2552300C2 |
| METHOD FOR DETECTING STAGE OF CHRONIC RENAL FAILURE IN NEPHROLOGICAL PATIENTS | 2000 |
|
RU2195161C2 |
| METHOD FOR PREDICTING CARDIOVASCULAR SYPHILIS | 2002 |
|
RU2210771C1 |
